Azacitidine is a medication used primarily in the treatment of certain types of cancer, particularly myelodysplastic syndromes (MDS). It belongs to a class of drugs known as DNA hypomethylating agents, which work by incorporating into DNA and RNA, leading to the reactivation of tumor suppressor genes and the suppression of oncogenes.
